Analysis Tools|
Allele Symbol Allele Name Allele ID |
Tagln+ wild type MGI:2440350 |
||||||||||||||||||||||||||||||||||||||||
| Summary |
9 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit normal Mendelian ratio after weaning
|
| N |
• mice exhibit normal retinal vascular development
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• superficial temporal artery is more branched than in controls
|
|
• at E11.5, carotid artery (CA) overbranching is observed
|
|
• vertebral artery (VA) caliber is increased relative to controls
|
|
• number of smooth muscle actin-positive cells in CA is half that observed in controls
|
|
• in the head, aneurysms are frequently observed
|
|
• in the head, hemorrhages are frequently observed
|
|
• number of smooth muscle actin-positive cells in CA is half that observed in controls
|
|
• in the head, hemorrhages are frequently observed
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• aortic root shows a approximate 30% reduction in lesion area and necrotic area compared to Apoetm1Unc Ddit3tm1.1Irt double homozygotes, indicating decreased atherosclerotic plaque progression
• smooth muscle cell content is lower in aortic arch lesions compared to Ddit3tm1.1Irt Apoetm1Unc double homozygotes
• mice on a Western diet show a lower content of alpha-actin-positive vascular smooth muscle cells in the lesions compared to Ddit3tm1.1Irt Apoetm1Unc double homozygotes
• lesions show decreased vascular smooth muscle cell proliferation
|
| N |
• after 12 weeks of Western diet feeding, mice exhibit similar body weight, blood glucose, total plasma cholesterol, HDL cholesterol, plasma triglycerides, and blood pressure as Apoetm1Unc Ddit3tm1.1Irt double homozygotes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased carotid artery section surface (increased vessel diameter) is observed
|
|
• a reduction in vascular smooth muscle cell (VSMC) coverage (depletion of mural cells) is observed
|
|
• a reduction in vascular smooth muscle cell (VSMC) coverage (depletion of mural cells) is observed
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• almost 50% of tamoxifen-treated animals die by 18 months from gastrointestinal obstruction (average lifespan 13.5 months); widespread gastrointestinal polyposis is found at time of necropsy
|
| N |
• with 2 intraperitoneal injections of tamoxifen at 6 weeks of age, no abnormalities are seen at 3 and 8 months of age
|
|
• at 11 months, gastrointestinal tract polyps are observed in <60% of tamoxifen-treated animals
• average polyp size is smaller than in Stk11tm1.2Rdp/+ mice at 11 months
|
|
• tumor formation (polyposis) in the gastrointestinal tract is increased greatly relative to controls
• tumors are characterized by a smooth muscle core, abundant stroma and hyperplastic epithelia without dysplasia
|
|
• at 11 months, mice present with severe gastrointestinal obstruction
|
|
• tumor formation (polyposis) in the gastrointestinal tract is increased greatly relative to controls
• tumors are characterized by a smooth muscle core, abundant stroma and hyperplastic epithelia without dysplasia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• 75% of tamoxifen-treated animals develop gastrointestinal polyposis by 11 months
• average size of polyps is comparable to that seen in double heterozygotes
|
|
• tumor formation (polyposis) in the gastrointestinal tract is increased greatly relative to controls
|
|
• tumor formation (polyposis) in the gastrointestinal tract is increased greatly relative to controls
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• reduced smooth muscle content and shorter overall smooth muscle coverage at birth
|
|
• less developed branching network of subepicardial conduit vessels
|
|
• reduced smooth muscle content and shorter overall smooth muscle coverage at birth
• reduced overall diameter of the coronary stems and reduced branching index
|
|
• reduced smooth muscle content and shorter overall smooth muscle coverage at birth
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice have a median survival time of 52 weeks
• this survival time is significantly longer than Prkg1tm2.1Naw homozygote that do not carry the knock-in allele
|
 |
• female mice have a reduced success rate of pregnancy
|
|
• mice have slightly reduced litter size of 3 to 6 pups
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice have a median survival time of 52 weeks
• this survival time is significantly longer than Prkg1tm2.1Naw homozygote that do not carry the knock-in allele
|
|
|
• female mice have a reduced success rate of pregnancy
|
|
• mice have slightly reduced litter size of 3 to 6 pups
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/13/2026 MGI 6.24 |
|
|
|
||
